Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The revision tag on the page updates from v3.6.2 to v3.6.3, indicating a new release version of the page. This typically reflects a minor update to the site's underlying system rather than changes to the page content.
    Difference
    0.1%
    Check dated 2026-07-04T13:30:17.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.6.2, replacing v3.6.0, indicating a new build of the ClinicalTrials.gov interface. The change does not modify the study history data or how the page operates.
    Difference
    0.1%
    Check dated 2026-06-27T06:22:38.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Recruitment status has been updated to 'no longer looking for participants,' indicating the trial is no longer actively seeking enrollees. The revision history also shows a new release labeled v3.6.0 and the prior v3.5.5 entry has been removed from the log.
    Difference
    0.2%
    Check dated 2026-06-13T05:15:11.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page history shows a new Revision: v3.5.5 replacing the previous v3.5.4, reflecting an update to the record history interface.
    Difference
    0.1%
    Check dated 2026-06-05T23:54:11.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new revision label v3.5.4 was added and the previous v3.5.3 revision was removed from the page history.
    Difference
    0.1%
    Check dated 2026-05-15T15:39:30.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The record history view was updated to include a newer submitted/revision entry (and corresponding UI revision version). This indicates an additional study history update affecting sections like Contacts/Locations and Study Status, rather than a major change to the core study description or outcomes.
    Difference
    0.3%
    Check dated 2026-04-24T05:56:07.000Z thumbnail image

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.